Furthermore, we correlated the elevated expression of SMC4 with a commensurately augmented expression of GLUT1 in prostate cancer metastasis, and cellular metabolic assays revealed that SMC4 knockdown suppressed glycolytic rate. This evidence concerns the gene SLC2A1 and prostate carcinoma.